A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 26,570 shares of ADPT stock, worth $219,733. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,570
Previous 23,829 11.5%
Holding current value
$219,733
Previous $122,000 30.33%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$4.37 - $6.78 $11,978 - $18,583
2,741 Added 11.5%
26,570 $159,000
Q3 2024

Nov 12, 2024

BUY
$3.37 - $5.12 $5,068 - $7,700
1,504 Added 6.74%
23,829 $122,000
Q2 2024

Aug 12, 2024

BUY
$2.34 - $3.96 $52,240 - $88,407
22,325 New
22,325 $80,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.18B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.